Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Sigma-Aldrich to Restructure Business into Three New Units

Published: Thursday, November 22, 2012
Last Updated: Thursday, November 22, 2012
Bookmark and Share
Sigma-Aldrich has provided the first details of a major restructuring that will align its organisation into three customer and market-focused business units.

The first of these will be the applied markets division and will serve the diagnostics, testing and industrial markets, with current research unit president Frank Wicks to head up this group.

International region boss Eric Green will lead the new research markets business, which focuses on operations in the life science, academic, government and hospital sectors, while Giles Cottier will continue to lead the SAFC division, which is being renamed as the SAFC Commercial Markets division.

Other organisational changes will see Gerrit van den Dool become managing director for Europe instead of North America and Jason Apter taking charge of the Asia-Pacific region.

Further details of the change, which will help Sigma-Aldrich to better address the needs of its global customers and to drive sales growth, will be revealed in early 2013.

Last month, the company published its financial report for the third quarter of 2012, during which its reported revenues rose by two percent year over year to $639 million (400.9 million pounds).

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SAFC Expands Carlsbad, Calif. Facility
Expansion to support commercial-scale gene therapy production, testing and filling.
Saturday, May 16, 2015
Sigma and Czech Center for Phenogenomics Collaborate
Sigma-Aldrich® and the Institute of Molecular Genetics, Czech Center for Phenogenomics, establish CRISPR core lab collaboration.
Friday, January 30, 2015
Sigma-Aldrich Licenses Foundational CRISPR Patents from Broad Institute
Company is able to make, use and distribute the advanced gene editing tools for numerous research applications.
Tuesday, December 09, 2014
Biotech firm inks deal with Sigma-Aldrich
Henrietta-based biotechnology company Diffinity Genomics Inc. has inked a non-exclusive global distribution deal with Sigma-Aldrich Co. LLC, the local company said.
Wednesday, November 30, 2011
Sigma-Aldrich® Receives National Institutes of Health Funding for Cardiovascular Disease Research
Sigma® Life Science to analyze plasma samples from FHS in researching novel biomarkers for cardiovascular disease.
Monday, August 09, 2010
Sigma-Aldrich Launches Breakthrough Genome-Editing Tools
CompoZr™ Zinc Finger Nuclease platform of reagents enables permanent and heritable modification of the genome.
Wednesday, September 17, 2008
Sigma-Aldrich Signs Exclusive Agreement with IsoSciences to Distribute Isotopically Labeled Bioactive Compounds
Under the terms of the agreement, IsoSciences will be the exclusive provider to Aldrich for their stable isotope products listed in the agreement for metabolic research.
Friday, September 12, 2008
Sigma-Aldrich Joins Phase 2 of the RNAi Consortium to Validate shRNA Libraries
Sigma-Aldrich to provide full functional validation data for its MISSION® shRNA collection.
Friday, May 09, 2008
Sigma-Aldrich Signs Licensing Agreement with Epigentek Group
Under the agreement, Sigma-Aldrich gains rights to core Epigentek including DNA modification, methylation quantitation and protein/DNA interaction.
Thursday, June 14, 2007
Sigma-Aldrich Announces the Aqua Peptide™ Partnership Program and Launch of the World's First Aqua Peptide Library
The Company will invite the proteomic researchers ordering custom AQUA Peptides to join its AQUA Peptide Partnership Program.
Tuesday, June 05, 2007
Sigma-Aldrich Welcomes Dublin City University to the RNAi Partnership Program
The Company aims to establish collaborations with select academic institutions to advance functional genomics research by aiding academic researchers with early exposure to emerging new techniques.
Tuesday, December 05, 2006
Sigma-Aldrich Forms RNAi Collaboration with Academic Research Leaders
Sigma-Aldrich established the RNAi Partnership Program to advance functional genomics research.
Monday, September 18, 2006
Sigma-Aldrich Expands Lentiviral shRNA Gene Family Sets
The MISSION™ TRC shRNA Human Kinases Gene Family is the second in a series of shRNA target sets that allows for RNAi cell-based screens in mammalian systems.
Wednesday, July 26, 2006
Scientific News
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
The Secret Behind the Power of Bacterial Sex
Migration between different communities of bacteria is the key to the type of gene transfer that can lead to the spread of traits such as antibiotic resistance, according to researchers at Oxford University.
Farming’s in Their DNA
Ancient genomes reveal natural selection in action.
GMO Food Animals Should be Judged by Product, Not Process
In a world with a burgeoning demand for meat, milk and eggs, regulatory policies around the use of biotechnologies in agriculture need to be based on the safety and attributes of those foods rather than on the methods used to produce them, says a UC Davis animal scientist.
Enzyme Critical to Maintaining Telomere Length Discovered
New method expected to speed understanding of short telomere diseases and cancer.
Gene Drive Reversibility Introduces New Layer of Biosafety
Ability to introduce or reverse the spread of genetic traits through populations could one day improve pest management and disease control.
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos